Whats new

Whats new.

Maxim Group - Late-Breaking Abstract for Eftilagimod Selected for SITC Press Conference (Analyst: Jason McCarthy)

November 7th 2022

For a copy of this analyst report please contact your Maxim analyst Jason McCarthy - jmccarthy@maximgrp.com

Go back